Sports

Galderma Highlights Recent Restylane Approvals At 30-Year Mark

Times News world desk (2026-10-06): (RTTNews) - Galderma Group AG (GALD.SW, GDERF) announced that its Restylane injectable aesthetic product line has reached its 30th anniversary since its… Primary source: original at Nasdaq Market Structure (nasdaq.com).

· Nasdaq Market Structure

Galderma Highlights Recent Restylane Approvals At 30-Year Mark

(RTTNews) - Galderma Group AG (GALD.SW, GDERF) announced that its Restylane injectable aesthetic product line has reached its 30th anniversary since its European launch. Restylane, which was introduced as a hyaluronic acid injectable, has since expanded into a portfolio of produc

Read at source